Академический Документы
Профессиональный Документы
Культура Документы
Training
Indications
The Cutera Titan handpiece is US FDA-cleared for topical heating for the purpose of elevating tissue temperature for temporary increase in local circulation where applied The Cutera Titan Handpiece is EU CE marked for the treatment of wrinkles Histologic evidence following Titan exposure shows collagen contraction
Zelickson B, Ross V, Kist D, Counters J, Davenport S, Spooner G. Ultrastructural Effects of an Infrared Handpiece on Forehead and Abdominal Skin. Dermatologic Surgery 2006;32:897-901
Spot Size
Spot Size: size of treatment window
Titan S and Titan V: 1.5 cm x 1 cm Titan XL: 3 cm x 1 cm Treatment window maintained at 20 C for epidermal cooling
Titan S
Titan V
Titan XL
General Considerations
The decision to treat with light therapy should be based upon appropriate diagnostic evaluation and consideration of all patient factors. The Titan Handpiece should only be operated by qualified practitioners who have received appropriate training and have thoroughly read the operator manual. Please consult the Titan Treatment Guidelines and the Operator Manual for additional information including indications for use, contraindications, possible adverse effects, safety warnings and features, and system operation. Appropriate parameters will vary. Always observe tissue reaction during treatment.
December, 2008 - D0777_Rev. A - Titan Mobile Technique 4
General Considerations
Proper patient screening, parameter selection, treatment technique, epidermal cooling, and tissue observation are important to achieve the desired outcome without unwanted side effects. It is important to observe tissue reaction during treatment. Excessive heating of the skin can increase the risk of blistering, burns, erosion, hyperpigmentation, and hypopigmentation; some of which may result in scarring.
5
Contraindications
Pregnant Patients Treatment of Skin Cancer
History of vitiligo
Heat from the treatment could induce a flare-up in patients with preexisting vitiligo.
10
11
12
Eye Safety
Safety eyewear must be worn by ALL people in the treatment room.
Example Operator Eyewear Patient Eyewear
13
14
Fluence Neck
38-44 J/cm2
Passes
3-6
3 to 5 treatments with an average of 4 week intervals. The number of exposures (pulses) required can vary significantly from patient to patient based on the size of the area to be treated.
*These parameters are based on physician feedback and provided as a guide only. Observe clinical response, patient discomfort and, area being treated to determine appropriate settings for each patient. See the Titan Treatment Guidelines for more information.
December, 2008 - D0777_Rev. A - Titan Mobile Technique
15
Mobile Technique
Allows for a significant increase in fluence compared to stationary method
Example: Stationary technique 36 J/cm2 Mobile technique 46 J/cm2
Move the handpiece in a small circular motion (approximately 20% of the crystal dimension) in all directions
Do NOT move the entire width of the crystal The movement should be continuous throughout the entire pulse
Crystal should be placed adjacent to prior placement as performed with the original stationary method (crystal edge to edge without overlap)
Crystal motion will overlap adjacent treated areas during treatment exposure See following animated placement slides
Clinical endpoint
Reach patient pain tolerance limit by end of last pass (note: tolerance assumes no anesthetic)
December, 2008 - D0777_Rev. A - Titan Mobile Technique 16
Mobile Technique
Move about 20% all directions
17
Mobile Technique
Move about 20% all directions Pulse 1 Pulse 2
Crystal should be placed adjacent to prior placement as performed with the original stamp method (crystal edge to edge without overlap) Crystal motion will overlap adjacent treated areas during treatment exposure
December, 2008 - D0777_Rev. A - Titan Mobile Technique
18
Always make sure to keep entire window in contact with the skin. Reduce fluence over sensitive or bony areas. Do not stack individual treatment pulses. Do not lift the handpiece until treatment pulse is complete.
19
Treatment Technique A
Divide face into smaller sections Treat one area with 3-6 passes before moving to next area
Repeat for each area on the face Move to neck and treat in the same manner
5 8 7 6
Place pulses adjacent to each other Do not stack pulses on one spot
20
Treatment Technique B
Treat small area with a minimum of 3-6 passes Average of 3-5 pulses per area Place pulses adjacent to each other Movement speed of crystal during treatment can vary according to patient tolerance Do not stack pulses on one spot
Titan XL Crystal Placement
4 3 2b 1b 1a 2a 2 1 5
21
Titan
Results may be subtle and/or delayed
Collagen remodeling takes 3-6 months Do not promise immediate results
PARAMETER SELECTION
Skin Type I-VI Including tanned skin Fluence Face 40-46 J/cm2 Fluence Neck 38-44 J/cm2 Passes
3-6
Common approach for treating: Fluence can be adjusted outside the given ranges as needed. Patient should be able to tolerate the treatment with no more than a moderate level of discomfort 3 to 5 treatments with an average of 4 week intervals The number of exposures (pulses) required can vary significantly from patient to patient based on the size of the area to be treated. These parameters are based on physician feedback and provided as a guide only. Observe clinical response, patient discomfort and, area being treated to determine appropriate settings for each patient. See the Titan Treatment Guidelines for more information.
TREATMENT TECHNIQUE
Allows for a significant increase in fluence compared to stationary method. Example: o Stationary method 36J/cm2 o Mobile technique 46 J/cm2 Move the handpiece in a small circular motion (approximately 20% of the crystal dimension) in all directions o Do NOT move the entire width of the crystal Crystal should be placed adjacent to prior placement as performed with the original stationary method (crystal edge to edge without overlap) o Crystal motion will overlap adjacent treated areas during treatment exposure o See animated slides on Titan Mobile Technique presentation or Titan Mobile Technique video for example Clinical Endpoint is reached when patient reaches pain tolerance limit by the end of third pass (note: tolerance assumes no anesthetic)